COVID-19 update: 190 new cases, 96 recoveries and one death

There are 190 new cases of COVID-19 and 96 recoveries to report in Saskatchewan on March 24, bringing the provincial total to 32,181 cases.

One (1) Saskatchewan resident who tested positive for COVID-19 has died. The death was reported in the 80+ age group from the North West zone.

article continues below

South East region reported nine new cases, with two of them located in Estevan’s Zone 4 (21 active cases), six in Weyburn’s Zone 3 and one in South East Zone 1.

The other new cases are located in the Far North West (7), Far North East (1), North West (10), North Central (2), North East (4), Saskatoon (26), Central East (5), Regina (116), South West (1) and South Central (2) zones. Seven (7) new cases are pending residence information. 

There are a total of 30,196 recoveries and 1,565 cases are considered active.  

One hundred forty-seven (147) people are in hospital. One hundred and twenty-five (125) people are receiving inpatient care: Far North West (4), Far North East (1), North West (6), North Central (6), North East (1), Saskatoon (41), Central East (7), Regina (46), South West (2), South Central (4) and South East (7).  Twenty-two (22) people are in intensive care: Saskatoon (8), Central East (2), Regina (11) and South Central (1).

The seven-day average of daily new cases is 173 (14.1 new cases per 100,000).  

There were 3,775 COVID-19 tests processed in Saskatchewan on March 23. 

To date, 640,259 COVID-19 tests have been processed in Saskatchewan.  As of March 22, when other provincial and national numbers were available, Saskatchewan's per capita rate was 536,498 tests performed per million population.  The national rate was 704,595 tests performed per million population.

As of March 23, 954 variants of concern (VOC) have been identified by screening in Saskatchewan, reported in the Far North East (1), Saskatoon (18), Central East (10), Regina (824), South Central (56) and South East (45) zones.  These have previously been reported as "presumptive positives" but all screening tests will be considered confirmed VOCs for the purposes of public reporting and contact investigations. Please note that these VOC may have been initially identified via means other than screening (i.e. selection for whole genome sequencing without screening) and that whole genome sequencing results to identify lineage are included in the screening results.

There are no new lineage results reported today. Of the 360 VOCs with lineages identified by whole genome sequencing in Saskatchewan, 352 are B1.1.1.7 (UK) and eight are B1.351 (SA).  The Regina zone accounts for 313 (or 87 per cent) of the VOC cases with confirmed lineage reported in Saskatchewan. 

Confirmed variant of concern cases may appear in both columns, depending on testing for that case.  Adding the cases identified by screening and those that have received whole genome sequencing may result in double-counting individual cases.   

Further statistics on the total number of cases among healthcare workers, breakdowns of total cases by source of infection, age, sex and region, total tests to date, the per capita testing rate and current numbers of confirmed variants of concern can be found on the Government of Saskatchewan website.  Please visit

Vaccination update

An additional 2,298 doses of COVID-19 vaccine have been given in Saskatchewan, bringing the total number of vaccines administered in the province to 151,507.

The 2,298 doses of COVID-19 vaccine reported today were administered in the following regions: Far North West (274), Far North East (66), North East (101), Saskatoon (953), Central West (119), Central East (147), South East (103) and Regina (1,177). The South East zone reported a data correction to remove 642 previously reported vaccinations.

The Pfizer shipments for Regina (15,210 doses) and Saskatoon (17,550) were received yesterday, with the Yorkton (3,510 doses) shipment expected to arrive on March 24 by end of day.  A Moderna shipment (24,200 doses) is expected Thursday, March 25.

The appointment booking system has expanded to include residents 65 years and older.  These residents are encouraged to book their COVID-19 vaccination and can do so online or by phone.  Additional information on eligibility and how to book your appointment is available at

More than two-thirds of Saskatchewan residents age 80 and over and 30 per cent of Saskatchewan residents in their 70s have now received their first dose.

Status of Priority Population Vaccinations, as of March 23, 2021


Estimated Population 

Received First Dose

Received Second Dose

LTC Residents


7,566 (90%)

5,230 (62%)

PCH Residents


4,264 (100%)

2,354 (55%)

Age 80+


34,940 (68%)

7,778 (15%)

Age 70-79


23,673 (30%)

3,948 (5%)

Phase 1 health care workers (includes LTC and PCH staff)


23,246 (57%)

14,605 (36%)

*An individual may be counted in more than one category (e.g., an 85 year-old LTC resident will be counted in the LTC resident category, the 70+ category and the 80+ category). Effective March 5, Saskatchewan implemented the delayed second dose policy.  This does not apply to residents of LTC and PCH and those priority Phase 1 individuals who had scheduled appointments to receive their second dose. All populations receiving vaccinations after March 5 will receive their second dose after all Saskatchewan adults have been offered their first dose. 

For a listing of first and second doses in Saskatchewan administered by geographic zone, visit

© Copyright Estevan Mercury


NOTE: To post a comment you must have an account with at least one of the following services: Disqus, Facebook, Twitter, Google+ You may then login using your account credentials for that service. If you do not already have an account you may register a new profile with Disqus by first clicking the "Post as" button and then the link: "Don't have one? Register a new profile".

The Estevan Mercury welcomes your opinions and comments. We do not allow personal attacks, offensive language or unsubstantiated allegations. We reserve the right to edit comments for length, style, legality and taste and reproduce them in print, electronic or otherwise. For further information, please contact the editor or publisher, or see our Terms and Conditions.

comments powered by Disqus